HIGH TIDE INC (HITI) Fundamental Analysis & Valuation
NASDAQ:HITI • CA42981E4013
Current stock price
2.32 USD
+0.04 (+1.75%)
Last:
This HITI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. HITI Profitability Analysis
1.1 Basic Checks
- In the past year HITI has reported negative net income.
- In the past year HITI had a positive cash flow from operations.
- In the past 5 years HITI always reported negative net income.
- Of the past 5 years HITI 4 years had a positive operating cash flow.
1.2 Ratios
- The Return On Assets of HITI (-13.49%) is better than 63.54% of its industry peers.
- HITI's Return On Equity of -52.89% is in line compared to the rest of the industry. HITI outperforms 51.04% of its industry peers.
- HITI's Return On Invested Capital of 6.12% is amongst the best of the industry. HITI outperforms 82.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -13.49% | ||
| ROE | -52.89% | ||
| ROIC | 6.12% |
ROA(3y)-11.05%
ROA(5y)-14.75%
ROE(3y)-30.28%
ROE(5y)-32.2%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Operating Margin of HITI (3.11%) is better than 78.65% of its industry peers.
- HITI's Operating Margin has improved in the last couple of years.
- The Gross Margin of HITI (26.05%) is comparable to the rest of the industry.
- In the last couple of years the Gross Margin of HITI has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.11% | ||
| PM (TTM) | N/A | ||
| GM | 26.05% |
OM growth 3YN/A
OM growth 5Y10.73%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.78%
GM growth 5Y-6.82%
2. HITI Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HITI is destroying value.
- HITI has more shares outstanding than it did 1 year ago.
- HITI has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, HITI has a worse debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of 1.77, we must say that HITI is in the distress zone and has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of 1.77, HITI is in the better half of the industry, outperforming 60.42% of the companies in the same industry.
- The Debt to FCF ratio of HITI is 5.97, which is a neutral value as it means it would take HITI, 5.97 years of fcf income to pay off all of its debts.
- HITI has a better Debt to FCF ratio (5.97) than 82.29% of its industry peers.
- HITI has a Debt/Equity ratio of 0.97. This is a neutral value indicating HITI is somewhat dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.97, HITI is doing worse than 72.40% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.97 | ||
| Debt/FCF | 5.97 | ||
| Altman-Z | 1.77 |
ROIC/WACC0.69
WACC8.82%
2.3 Liquidity
- A Current Ratio of 1.43 indicates that HITI should not have too much problems paying its short term obligations.
- HITI has a Current ratio of 1.43. This is in the lower half of the industry: HITI underperforms 75.00% of its industry peers.
- A Quick Ratio of 0.72 indicates that HITI may have some problems paying its short term obligations.
- HITI has a Quick ratio of 0.72. This is amonst the worse of the industry: HITI underperforms 84.90% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.43 | ||
| Quick Ratio | 0.72 |
3. HITI Growth Analysis
3.1 Past
- HITI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -519.69%.
- HITI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.36%.
- HITI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 48.14% yearly.
EPS 1Y (TTM)-519.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%145.64%
Revenue 1Y (TTM)17.36%
Revenue growth 3Y18.51%
Revenue growth 5Y48.14%
Sales Q2Q%23.57%
3.2 Future
- The Earnings Per Share is expected to grow by 30.45% on average over the next years. This is a very strong growth
- HITI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.19% yearly.
EPS Next Y122.26%
EPS Next 2Y58.17%
EPS Next 3Y39.81%
EPS Next 5Y30.45%
Revenue Next Year23.35%
Revenue Next 2Y17.96%
Revenue Next 3Y16.48%
Revenue Next 5Y13.19%
3.3 Evolution
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. HITI Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for HITI. In the last year negative earnings were reported.
- HITI is valuated reasonably with a Price/Forward Earnings ratio of 10.38.
- Based on the Price/Forward Earnings ratio, HITI is valued cheaper than 87.50% of the companies in the same industry.
- HITI is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.69, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 10.38 |
4.2 Price Multiples
- 90.63% of the companies in the same industry are more expensive than HITI, based on the Enterprise Value to EBITDA ratio.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of HITI indicates a rather cheap valuation: HITI is cheaper than 87.50% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.06 | ||
| EV/EBITDA | 7.68 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- HITI's earnings are expected to grow with 39.81% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y58.17%
EPS Next 3Y39.81%
5. HITI Dividend Analysis
5.1 Amount
- HITI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
HITI Fundamentals: All Metrics, Ratios and Statistics
NASDAQ:HITI (4/8/2026, 8:00:02 PM)
2.32
+0.04 (+1.75%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-17 2026-03-17/amc
Earnings (Next)06-15 2026-06-15
Inst Owners13.93%
Inst Owner Change0%
Ins Owners8.84%
Ins Owner ChangeN/A
Market Cap203.93M
Revenue(TTM)629.85M
Net Income(TTM)-46.73M
Analysts80
Price Target5.32 (129.31%)
Short Float %0.41%
Short Ratio0.61
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)0.63%
Min Revenue beat(2)0.29%
Max Revenue beat(2)0.98%
Revenue beat(4)3
Avg Revenue beat(4)0.22%
Min Revenue beat(4)-1.49%
Max Revenue beat(4)1.09%
Revenue beat(8)6
Avg Revenue beat(8)0.25%
Revenue beat(12)9
Avg Revenue beat(12)0.49%
Revenue beat(16)13
Avg Revenue beat(16)7.31%
PT rev (1m)0%
PT rev (3m)-0.26%
EPS NQ rev (1m)-150.04%
EPS NQ rev (3m)-166.7%
EPS NY rev (1m)0%
EPS NY rev (3m)1.99%
Revenue NQ rev (1m)-3.48%
Revenue NQ rev (3m)-2.16%
Revenue NY rev (1m)-2.3%
Revenue NY rev (3m)-4.88%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 10.38 | ||
| P/S | 0.45 | ||
| P/FCF | 15.06 | ||
| P/OCF | 9.77 | ||
| P/B | 3.21 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.68 |
EPS(TTM)-0.41
EYN/A
EPS(NY)0.22
Fwd EY9.64%
FCF(TTM)0.15
FCFY6.64%
OCF(TTM)0.24
OCFY10.24%
SpS5.15
BVpS0.72
TBVpS-0.32
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -13.49% | ||
| ROE | -52.89% | ||
| ROCE | 7.75% | ||
| ROIC | 6.12% | ||
| ROICexc | 7.18% | ||
| ROICexgc | 17.59% | ||
| OM | 3.11% | ||
| PM (TTM) | N/A | ||
| GM | 26.05% | ||
| FCFM | 2.99% |
ROA(3y)-11.05%
ROA(5y)-14.75%
ROE(3y)-30.28%
ROE(5y)-32.2%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y8.85%
ROICexc growth 3YN/A
ROICexc growth 5Y9.97%
OM growth 3YN/A
OM growth 5Y10.73%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.78%
GM growth 5Y-6.82%
F-Score2
Asset Turnover1.82
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.97 | ||
| Debt/FCF | 5.97 | ||
| Debt/EBITDA | 1.86 | ||
| Cap/Depr | 38.53% | ||
| Cap/Sales | 1.62% | ||
| Interest Coverage | 2.48 | ||
| Cash Conversion | 63.05% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.43 | ||
| Quick Ratio | 0.72 | ||
| Altman-Z | 1.77 |
F-Score2
WACC8.82%
ROIC/WACC0.69
Cap/Depr(3y)33.59%
Cap/Depr(5y)35.25%
Cap/Sales(3y)1.64%
Cap/Sales(5y)2.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-519.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%145.64%
EPS Next Y122.26%
EPS Next 2Y58.17%
EPS Next 3Y39.81%
EPS Next 5Y30.45%
Revenue 1Y (TTM)17.36%
Revenue growth 3Y18.51%
Revenue growth 5Y48.14%
Sales Q2Q%23.57%
Revenue Next Year23.35%
Revenue Next 2Y17.96%
Revenue Next 3Y16.48%
Revenue Next 5Y13.19%
EBIT growth 1Y51.49%
EBIT growth 3YN/A
EBIT growth 5Y64.03%
EBIT Next Year690.23%
EBIT Next 3Y135.81%
EBIT Next 5Y77.27%
FCF growth 1Y-0.6%
FCF growth 3YN/A
FCF growth 5Y16.8%
OCF growth 1Y14.26%
OCF growth 3Y74.46%
OCF growth 5Y21.95%
HIGH TIDE INC / HITI Fundamental Analysis FAQ
What is the fundamental rating for HITI stock?
ChartMill assigns a fundamental rating of 4 / 10 to HITI.
What is the valuation status for HITI stock?
ChartMill assigns a valuation rating of 6 / 10 to HIGH TIDE INC (HITI). This can be considered as Fairly Valued.
What is the profitability of HITI stock?
HIGH TIDE INC (HITI) has a profitability rating of 4 / 10.
How financially healthy is HIGH TIDE INC?
The financial health rating of HIGH TIDE INC (HITI) is 3 / 10.